Time for another ‘Article of Interest’ post.  This is now the 16th post in this series, with the previous one dropping last month.  This time I point you to another Kiplinger’s article.  It was released earlier this week.  This article lists the 16 best value stocks for the remainder of this year.  How ironic is that… 16 value stocks for my 16th post.  🙂

To recap the intent of this series… every now and then, when perusing investing or personal finance articles across the Internet, I come across what I call an ‘Article of Interest’, or ‘A of I’ for short.

I decided it might be helpful to share a link to the article(s) in case some of my visitors would find it of interest as well.

In most cases, the articles will focus on dividend-paying stocks or dividend growth investing (DGI).  However, other finance-related topics might be highlighted, too.

Now that we are up-to-speed, let’s get more details on what this A of I is about…

 

Link Overview

In recent years, growth stocks have been the ones to perform best, with value stocks lagging behind.  However, in 2021, value stocks have been performing well, making up some lost ground.

Kiplinger’s list includes high-quality value stocks that have above-average dividend payouts and appear poised to benefit from a economy that continues to strengthen as part of the recovery from the COVID-19 pandemic.

For the 16 stocks chosen in the article, their dividend yields generally range from 1.8% to 4.5%, but there is one outlier at 6.9%.

In terms of company market capitalization, none of the stocks are small-caps, but 5 of the 16 can be categorized as mid-cap ($2B to $10B).

Furthermore, the remaining 11 can be designated as large-cap stocks ($10B+), with 2 of those being big enough to classify as mega-cap ($200B+).

Value stocks seem to have disproportionately took it on the chin during this past week of stock market trading.  Thus, you may find that the 16 stocks chosen are less expensive than the prices listed in the article.  So, who knows… if they were values before, perhaps they are even better ones now.

 

Each stock making the list comes with a brief status/review, as well as the following info:

• Market Value
• Dividend Yield

The stocks don’t appear to be listed in any particular order.

 

https://www.kiplinger.com/investing/stocks/value-stocks/602945/best-value-stocks-2021

 

I found that I own 3 of the 16 stocks from the list in my Portfolio.  These stocks are Merck & Co. (MRK), AbbVie (ABBV) and Altria Group (MO).  MRK happens to be a position I started late last year and have been growing rather aggressively since then.  Obviously I’ve seen value in that stock.

Removing those 3 stocks from the list, that leaves me with 13 candidates for further investigation.  I looked at Huntington Ingalls Industries (HII) several months ago in one of my Portfolio Thoughts posts.  In addition, Bristol Myers Squibb (BMY) has been on my watchlist for the past few months.

 

How many of the 16 stocks from the article are already present in your portfolio?  Are any of these stocks currently on your watchlist?

 

I hope you find the article useful and/or enjoyable.  As always, please share your thoughts once you’ve had a chance to read the material.

See you next time…